Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

Summary by Hastings Tribune
LEXINGTON, Mass.--(BUSINESS WIRE)--Jul 25, 2025-

1 Articles

Hastings TribuneHastings Tribune
Center

Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

LEXINGTON, Mass.--(BUSINESS WIRE)--Jul 25, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Friday, July 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Lexington, Massachusetts icon

Lexington, Massachusetts

News
For You
SearchBlindspotLocal